In conclusion, the results of the present study demonstrated that, in comparison to EGCG, kaempferol has larger antiproliferative and proapoptotic impacts on human leukemia HL60 cells by increasing CASP8 and intracellular BAX/BCL2 ratio and reducing the expressions of MDR-associated genes in the long term. Here, BCL2 is linked to leukemia.